Hector Romero Garcia ’26 — the URECA researcher of the month for September — is a biochemistry major who joined Christopher Clarke’s Lipid Cancer Laboratory this past summer as a participant in the SUNY SOAR...
An FABP inhibitor developed by Stony Brook University researchers has been cleared by the FDA to help curb pain and inflammation related to cancer treatment.
STONY BROOK, NY, June 18, 2024 – Breast cancer research at the Stony Brook Cancer Center is taking a long-lasting, impactful leap forward thanks to the generous support from the Carol M. Baldwin Breast Cancer...
Supporting Children Affected by a Parent’s Cancer Stony Brook, NY, May 1, 2024 – Five million children in the United States are coping with a parent’s cancer. Kesem at Stony Brook University (SBU) supports these...
Stony Brook University signs licensing agreement with Perspective Therapeutics Image-guided radionuclide therapy uses radioactive molecules designed to specifically target and kill cancer cells while sparing non...